10 Things You Need to Know for Monday
What to look for as we fire up a fresh five-session set.
After a hard-fought effort on the short side for two weeks—and losing roughly 10 handles before finally getting stopped out on Wednesday, I turned around Thursday morning and laid into the tape (read: initiated a fresh round of shorts in and around S&P (INDEXSP:.INX) 1530).
"Don't trade scared," I reminded myself as I slapped on the risk, and the tape rewarded me with a 30-handle slide in 24 hours.
Indeed, after a frustrating string of sessions, I got short at S&P 1530, covered half at S&P 1515 (a few hours later), and covered the balance at S&P 1500 the following morning (in real-time on the Buzz & Banter; the confluence of S&P 1500 and NDX 2700, as offered at the time, was an intuitive place for the bulls to circle their wagons).
While naked (read: flat in my trading account), I watched the tape for a few hours on Thursday before unleashing a fresh batch of shorts midday. With a three-day weekend ahead—I took a personal day Friday—I was debating whether or not to hold that downside exposure over the weekend, before sharing the following on the Buzz at the end of the session:
While away from the fray on Friday, I checked on the tape several times, whispering discipline over conviction to nobody in particular as the market rallied; the mechanics of the swing once again trumped the results of the at-bat.
I figured the S&P would rally to where it should have closed on a Friday—right to S&P 1515, which was support and resistance several times over the last few weeks. If everything went according to the master plan, the tape would subsequently fade (lower) this morning but alas, Mr. Market didn't get that memo yet (see the importance of S&P 1515 below).
There’s no shame in admitting it’s hard, only shame in pretending it’s not, right? With that in mind, here are 10 things you need to know for this Monday:
1. I’ve started this week with a bag full of dry powder, flat risk on my trading pad, and eyes wide open looking for advantageous risk-reward.
2. Europe is screaming higher (on the back of the Italian elections) and the first move for US equities is higher, albeit not as high as it was, as select financials (Goldman Sachs (NYSE:GS), JPMorgan (NYSE:JPM), Morgan Stanley (NYSE:MS)) fade into Red Dye (the financial stocks are one of our best intraday trading tells).
3. It's N's over S's (NDX (INDEXNASDAQ:NDX) outperformance of SPX (INDEXSP:.INX)) to start the week.
4. Goldman was a terrific tell last week, as was Facebook (NASDAQ:FB) ($28 is the technical toggle, for those looking for defined risk).
5. Market breadth remains more or less flat today; we need to see a 2:1 posture (either way) for it to qualify as a tell. And yes, I continue to watch the relationship between commodities and the S&P for obvious reasons.
6. For all of you looking for lower prices at the pump, be careful for what you wish.
7. Per Jeff Cooper's excellent missive, one of the better quotes I’ve heard in a while:
8. S&P 1475-1480 will be trend line support for the S&P, if and when and per the chart below. The more meaningful level will be IF we get up toward S&P 1575-1580, as that will bring the second chart below into play—with very defined risk for those looking to fade (lower).
9. Over on the Nasdaq, you can see why NDX 2700 was so important, and why we’ve been monitoring the levels we’ve been monitoring, both ways.
10. In hindsight, my trading platform may have done me a favor in putting some of my cannabis vehicles on the "chill" list. I still believe in the thesis; I'm just not entirely sure what the best way to play it is.
And, one for the “life is what happens when you’re making other plans” file:
I went to visit my friends at the Hospital for Special Surgery on Thursday. The good news is that my herniated disks haven’t gotten worse. The bad—or better news, depending on how you look at it—is that I have congenital hip dysplasia which “barring a miracle” will require a full-fledged hip replacement. (Take a moment to let this visual sink in!)
This doesn’t upset me; I’m actually psyched to be pain-free for the first time in years. I’ve got an MRI scheduled for tomorrow night, an injection Thursday morning and perhaps some stem cell treatments in a month. If I improve, terrific; if not, Steve Austin better watch his back! And yes, this has been some year on the health front!
Follow Todd and over 30 professional traders as they share their ideas in real-time with a FREE 14 day trial to Buzz & Banter.
Todd Harrison is the founder and Chief Executive Officer of Minyanville. Prior to his current role, Mr. Harrison was President and head trader at a $400 million dollar New York-based hedge fund. Todd welcomes your comments and/or feedback at email@example.com.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.